Pharmaceuticals
Delhi HC bars export of Natco's generic cancer drug on Bayer’s plea
27 Mar 2014
Bayer, in its petition, has pointed out that the generic drug being made under compulsory licence is for sale in India and, thus, cannot be exported
India ready to defend its IPR norms at WTO: Sharma
24 Mar 2014
Commerce and industry minister Anand Sharma said if the US wanted to raise India's IPR policy at the WTO, India was ready for it
And now, USFDA bans imports from Sun Pharma unit
13 Mar 2014
The US regulator has been cracking down heavily on Indian generic pharmaceutical firms such as Ranbaxy and Wockhardt for alleged failure to comply with its manufacturing norms
GSK spends $1.05 bn to raise stake in Indian arm
11 Mar 2014
GlaxoSmithKline Plc (GSK) yesterday said that it has paid £625 million ($1.05 billion) to increase its stake in its Indian subsidiary GSK Pharmaceuticals to 75 per cent
Shocking dosage mix-up forces Ranbaxy to recall generic Liptor in US
08 Mar 2014
Quality concerns about India's $14 billion drug industry have come to the fore after the US FDA banned plants run by Ranbaxy and Wockhardt Ltd from sending drugs to the US, for failure to meet manufacturing standards
May collaborate, not take over Roche: Novartis
03 Mar 2014
Novartis, which holds a third of Roche's bearer shares, has once again scotched reports of acquiring its Swiss rival, Roche
Drug CRO Medpace to be sold to European PE firm Cinven for $915 mn
25 Feb 2014
European buyout firm Cinven Ltd yesterday confirmed that it will acquire pharmaceutical contract research company Medpace Inc for $915 million from CCMP Capital Advisor
Bayer close to bagging cancer drug maker Algeta for $2.9-bn
24 Feb 2014
German healthcare major Bayer AG today said that it is close to completing its $2.9-billion acquisition of Algeta, after 92.17 per cent shareholders of the Norwegian cancer drug maker tendered their shares to the offer
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation